Literature DB >> 19726541

Importance of gender-specific calcitonin thresholds in screening for occult sporadic medullary thyroid cancer.

Andreas Machens1, Florian Hoffmann, Carsten Sekulla, Henning Dralle.   

Abstract

Men and women differ in thyroidal C-cell mass and calcitonin secretion. This difference may have implications for the definition of calcitonin thresholds to distinguish sporadic C-cell hyperplasia from occult medullary thyroid cancer. This retrospective study examined the hypothesis that gender-specific calcitonin thresholds predict occult medullary thyroid cancer more accurately among patients with increased basal calcitonin levels than unisex thresholds. A total of 100 consecutive patients were evaluated with occult sporadic C-cell disease no larger than 10 mm who were referred for increased basal calcitonin levels and underwent pentagastrin stimulation preoperatively at this institution. Altogether, gender-specific calcitonin thresholds predicted medullary thyroid cancer better than unisex thresholds. At lower (<or=50 pg/ml basally; <or=500 pg/ml after stimulation), but not higher, calcitonin serum levels, women revealed medullary thyroid cancer four to eight times more often than men. Most discriminatory between C-cell hyperplasia and medullary thyroid cancer was a basal calcitonin threshold of 15 pg/ml (corrected 20 pg/ml) for women and 80 pg/ml (corrected 100 pg/ml) for men, based on the greatest accuracy at the lowest possible calcitonin level. The respective gender-specific stimulated peak calcitonin thresholds were 80 pg/ml (corrected 100 pg/ml) and 500 pg/ml. Corresponding positive predictive values for medullary thyroid cancer at these calcitonin thresholds were 89 and 90% for women, as opposed to 100% for men. To increase the positive predictive value for women to 100%, the respective calcitonin thresholds would have to be raised to 40 pg/ml (corrected 50 pg/ml) and 250 pg/ml. These findings indicate that gender-specific calcitonin thresholds predict sporadic occult medullary thyroid cancer better than unisex thresholds.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19726541     DOI: 10.1677/ERC-09-0136

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  13 in total

1.  RET proto-oncogene mutations are restricted to codon 618 in Cypriot families with multiple endocrine neoplasia 2.

Authors:  V Neocleous; N Skordis; G Portides; E Efstathiou; C Costi; N Ioannou; M Pantzaris; V Anastasiadou; C Deltas; L A Phylactou
Journal:  J Endocrinol Invest       Date:  2011-03-21       Impact factor: 4.256

Review 2.  Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment.

Authors:  Shabina R Ahmed; Douglas W Ball
Journal:  J Clin Endocrinol Metab       Date:  2011-02-23       Impact factor: 5.958

Review 3.  [Calcitonin determination for early diagnosis of medullary thyroid cancer].

Authors:  W Karges
Journal:  Chirurg       Date:  2010-07       Impact factor: 0.955

4.  Stimulated calcitonin cut-offs by different tests.

Authors:  Laura Fugazzola
Journal:  Eur Thyroid J       Date:  2013-01-16

Review 5.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

6.  Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin.

Authors:  Kerstin Lorenz; Malik Elwerr; Andreas Machens; Mohammed Abuazab; Hans-Jürgen Holzhausen; Henning Dralle
Journal:  Langenbecks Arch Surg       Date:  2013-02-14       Impact factor: 3.445

7.  Calcitonin testing for detection of medullary thyroid cancer in people with thyroid nodules.

Authors:  Hans Hg Verbeek; Jan Willem B de Groot; Wim J Sluiter; Anneke C Muller Kobold; Edwin R van den Heuvel; John Tm Plukker; Thera P Links
Journal:  Cochrane Database Syst Rev       Date:  2020-03-16

Review 8.  A review on the association between glucagon-like peptide-1 receptor agonists and thyroid cancer.

Authors:  Wei-Yih Chiu; Shyang-Rong Shih; Chin-Hsiao Tseng
Journal:  Exp Diabetes Res       Date:  2012-05-28

9.  Acting on Hormone Receptors with Minimal Side Effect on Cell Proliferation: A Timely Challenge Illustrated with GLP-1R and GPER.

Authors:  Véronique Gigoux; Daniel Fourmy
Journal:  Front Endocrinol (Lausanne)       Date:  2013-04-29       Impact factor: 5.555

10.  A Genomic Alternative to Identify Medullary Thyroid Cancer Preoperatively in Thyroid Nodules with Indeterminate Cytology.

Authors:  Richard T Kloos; Robert J Monroe; S Thomas Traweek; Richard B Lanman; Giulia C Kennedy
Journal:  Thyroid       Date:  2016-04-22       Impact factor: 6.568

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.